Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial (Q82866936)
Jump to navigation
Jump to search
scientific article published on 01 January 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial |
scientific article published on 01 January 2006 |
Statements
Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial (English)
Andrew M Luks
Erik R Swenson
Buddha Basnyat
Jeffrey H Gertsch
Peter S Holck
E William Johnson
Benjamin P Donham
Ross J Fleischman
Daniel W Gowder
Jason S Hawksworth
Brett T Jensen
Richard J Kleiman
Adam H Loveridge
Elizabeth B Lundeen
Sheri L Newman
Jesse A Noboa
Daniel P Miegs
Kenneth A O'Beirne
Kelly B Philpot
Miriam N Schultz
Matthew C Valente
Mandie R Wiebers